NMPA Approval

Salbutamol Sulfate Inhalation Aerosol

Approval Number

国药准字J20160074

CompanyGlaxosmithkline Australia Pty Ltd.

Registration Date

September 18, 2016

Previous Approval Numbers

H20150673

Drug Information

Generic Name

硫酸沙丁胺醇吸入气雾剂

Dosage Form

气雾剂

Strength

100ug/揿

Drug Type

化学药品

Registration Date

September 18, 2016

Company Information

Applicant Company

Company NameGlaxosmithkline Australia Pty Ltd.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

硫酸沙丁胺醇吸入气雾剂 - NMPA 批准文号 | MedPath